Correlation Between Larimar Therapeutics and Ocugen

Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Ocugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Ocugen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Larimar Therapeutics and Ocugen Inc, you can compare the effects of market volatilities on Larimar Therapeutics and Ocugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Ocugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Ocugen.

Diversification Opportunities for Larimar Therapeutics and Ocugen

0.27

Correlation Coefficient

Larimar Therapeutics  Ocugen

Modest diversification

The 3 months correlation between Larimar and Ocugen is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Ocugen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocugen Inc and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Ocugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocugen Inc has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Ocugen go up and down completely randomly.

Pair Corralation between Larimar Therapeutics and Ocugen

Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 1.22 times more return on investment than Ocugen. However, Larimar Therapeutics is 1.22 times more volatile than Ocugen Inc. It trades about 0.0 of its potential returns per unit of risk. Ocugen Inc is currently generating about -0.1 per unit of risk. If you would invest  669.00  in Larimar Therapeutics on September 16, 2024 and sell it today you would lose (52.00) from holding Larimar Therapeutics or give up 7.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Larimar Therapeutics  vs.  Ocugen Inc

Larimar Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Larimar Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Ocugen Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ocugen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Larimar Therapeutics and Ocugen

The main advantage of trading using opposite Larimar Therapeutics and Ocugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Ocugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocugen will offset losses from the drop in Ocugen's long position.

The idea behind Larimar Therapeutics and Ocugen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.